These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


214 related items for PubMed ID: 1981390

  • 21. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
    Amagase K, Kato S, Yamamoto H, Okabe S.
    Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
    [Abstract] [Full Text] [Related]

  • 22. Suppression of gastric acidity in horses.
    Murray MJ.
    J Am Vet Med Assoc; 1997 Jul 01; 211(1):37-40. PubMed ID: 9215408
    [No Abstract] [Full Text] [Related]

  • 23. A review of the animal pharmacology of ranitidine--a new, selective histamine H2-antagonist.
    Brittain RT, Daly MJ.
    Scand J Gastroenterol Suppl; 1981 Jun 01; 69():1-9. PubMed ID: 6119770
    [Abstract] [Full Text] [Related]

  • 24. The effect of different histamine H2-receptor antagonists on the gastric acid secretion of the isolated whole stomach of the mouse and on the heart rate of spontaneously beating atrium of the guinea-pig.
    Szelenyi I, Postius S.
    Arzneimittelforschung; 1984 Jun 01; 34(7):787-8. PubMed ID: 6149753
    [Abstract] [Full Text] [Related]

  • 25. [Studies of an experimental model of asthma in monkeys. The effect of H1 and H2 histamine antagonists on bronchoconstriction induced by histamine and methacholine aerosol challenge].
    Ishihara T, Mue S, Ohmi T, Tamura G, Sekizawa K, Huyuki T, Chonan T, Hoshi S, Ohtsu H, Sasaki T, Takishima T.
    Arerugi; 1982 Sep 01; 31(9):970-6. PubMed ID: 6129839
    [No Abstract] [Full Text] [Related]

  • 26. [Gastric ulcer caused by digestive juice reflex].
    Chrubasik S, Schusziarra V.
    Med Klin; 1981 Jul 17; 76(15):423-5, 42. PubMed ID: 6114392
    [No Abstract] [Full Text] [Related]

  • 27. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
    Lazzaroni M, Bianchi Porro G.
    Ital J Gastroenterol Hepatol; 1999 Jul 17; 31 Suppl 1():S73-8. PubMed ID: 10379473
    [Abstract] [Full Text] [Related]

  • 28. [The histoenzymological and ultrastructural changes in the gastric mucosa in peptic ulcer after treatment with pirenzepine and histamine H2-receptor blockaders].
    Degtiareva II, Kharchenko NV, Lodianaia EV, Zukheĭr Kh, Tokar' DV, Nevstruev VP, Piletskiĭ AM.
    Lik Sprava; 1995 Jul 17; (1-2):48-51. PubMed ID: 7483543
    [Abstract] [Full Text] [Related]

  • 29. Pharmacological properties of histamine receptor subtypes.
    Arrang JM.
    Cell Mol Biol (Noisy-le-grand); 1994 May 17; 40(3):275-81. PubMed ID: 7920174
    [Abstract] [Full Text] [Related]

  • 30. Reduction of ventricular fibrillation threshold by histamine: resolution into separate H1- and H2-mediated components.
    Trzeciakowski JP, Levi R.
    J Pharmacol Exp Ther; 1982 Dec 17; 223(3):774-83. PubMed ID: 6128405
    [Abstract] [Full Text] [Related]

  • 31. [Autacoid blockaders. 1. Effects of histamine and of blockaders].
    Karashima T, Hara Y, Kamata M, Kuriyama H.
    Nihon Rinsho; 1979 Dec 17; 37(7):2853-9. PubMed ID: 43408
    [No Abstract] [Full Text] [Related]

  • 32. [Effect of blockaders of biogenic amine receptors on experimental ulcer development].
    Karevina TG, Shevchuk IM.
    Farmakol Toksikol; 1988 Dec 17; 51(4):56-60. PubMed ID: 2847940
    [Abstract] [Full Text] [Related]

  • 33. Mixed antisecretory and gastroprotective activities of a new H2-antagonist containing a nitric oxide-donor furoxan moiety.
    Sorba G, Gasco A, Coruzzi G, Adami M, Pozzoli C, Morini G, Bertaccini G.
    Arzneimittelforschung; 1997 Jul 17; 47(7):849-54. PubMed ID: 9272244
    [Abstract] [Full Text] [Related]

  • 34. Animal pharmacology of the selective histamine H1-receptor antagonist tazifylline.
    Poizot A, Dumez D, Ferrandon P, Lefournier C, Michel A, Armstrong JM.
    Arzneimittelforschung; 1986 Apr 17; 36(4):695-702. PubMed ID: 2424463
    [Abstract] [Full Text] [Related]

  • 35. Isolated gastric mucosa: an early approach to the study of the mechanism of action of gastric antisecretory agents.
    Colombo M, Fort M, Farré AJ.
    Methods Find Exp Clin Pharmacol; 1989 Oct 17; 11(10):621-34. PubMed ID: 2573753
    [Abstract] [Full Text] [Related]

  • 36. [Famotidine. Pharmacologic and clinical profile of the new histamine H2 receptor antagonist].
    Müller P, Dammann HG, Simon B.
    Fortschr Med; 1986 Apr 17; 104(15):319-22. PubMed ID: 2872147
    [No Abstract] [Full Text] [Related]

  • 37. [Acid secretory rebound after gastric antisecretory treatment. Above all, a problem for the physiologists!].
    Vallot T, Mignon M.
    Gastroenterol Clin Biol; 1994 Apr 17; 18(8-9):677-9. PubMed ID: 7875433
    [No Abstract] [Full Text] [Related]

  • 38. [Successful therapy of a severe dextran incident using histamin H1- and H2-receptor blockaders].
    Lindenmaier HL, Preiss D, Kuner EH.
    Chirurg; 1978 Aug 17; 49(8):514-6. PubMed ID: 28913
    [Abstract] [Full Text] [Related]

  • 39. Action of H1 and H2 inhibitors on the response of histamine sensitive adenyly cyclase from guinea-pig mucosa.
    Perrier CV, Griessen M.
    Eur J Clin Invest; 1976 Jan 30; 6(1):113-20. PubMed ID: 3419
    [Abstract] [Full Text] [Related]

  • 40. Potential histamine H2-receptor antagonists. 4. Benzylhistamines.
    Emmett JC, Durant GJ, Ganellin CR, Roe AM, Turner JL.
    J Med Chem; 1982 Oct 30; 25(10):1168-74. PubMed ID: 6128418
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.